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Abstract: In order to quantify the amount of ligands or poly(ethylene glycol) (PEG) on each 
vector, here we developed a system in which poly-L-glutamic acid (PLG) was used as surface 
modiﬁ  cation loading backbone, to which one PEG (MW 5000, 10000, 20000) or epidermal 
growth factor (EGF) was linked. The PLG conjugates can electro-statically adsorb upon DNA/
polycation complex with positive charge, and, the amount of EGF or PEG on the surface of 
complexes could be varied. We have made a series of complexes containing the various PLG 
conjugates and examined their physicochemical properties, and made a comparison of proper-
ties and transfection efﬁ  ciency between these complexes. EGF- and PEG-modiﬁ  ed complexes 
showed 10–25-folds higher cell transfection efﬁ  ciency than unmodiﬁ  ed complexes in medium 
with or without serum.
Keywords: gene delivery, poly(ethylene glycol), poly-L-glutamic acid, epidermal growing 
factor, poly-L-lysine
Introduction
In recent years, nonviral gene delivery system was widely used in gene delivery due 
to no or little risk of immune response and large-scale manufacturing compared with 
viral gene carriers (Merdan et al 2002; Ogris and Wagner 2002).
Sukhorukov and colleagues (1998) showed that the development of nanoparticles 
by stepwise layer-by-layer deposition of alternatively charged polyelectrolyte onto 
polystyrene and melamine formaldehyde latex particles that are able to encapsulate 
different pharmacological agents, proteins, and so on. Based on their studies, Zait-
sev and colleagues (2004) made some compact particles with negative charge and 
low aggregation capacity under physiological conditions for nonviral gene delivery 
systems by depositing polyanion (PVS or transfer RNA) to DNA/polyethylenimine 
(PEI) complex. This approach was ﬁ  rstly used for DNA encapsulation with a DNA/
poly-L-lysine (PL L) core by Trubetskoy and colleagues (1999), in which PLL and 
succinylated PLL as polycation and polyanion, respectively, was used to deposit 
alternating layer of polyanion and polycation on the surface of positive DNA/PLL 
complex. These complexes with layer of alternating layer of polyanion and polyca-
tion was physicochemically characterized. Transfection activity of these complexes 
was shown by these authors later (Trubetskoy et al 2003). Maruyama and colleagues 
(2004) used PEG derivative containing carboxylic acid and lactose side chain 
(Lac-PEG-C) to deposit on the surface of DNA/protamine complex with positive 
charges, and then obtained 56-fold higher transfection efﬁ  ciency with DNA/prot-
amine/Lac-PEG-C at weight ratio 1:1.5:8 than that without Lac-PEG-C (Maruyama 
et al 2004). Other researchers also made use of DNA/polycation complexes modi-
ﬁ  ed with PEG derivatives having carboxylic acid and/or sugar and received certain International Journal of Nanomedicine 2008:3(2) 250
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effects (Koyama et al 2002, 2003). These DNA/polycation 
complexes modiﬁ  ed with PEG derivatives showed a strong 
resistance against the albumin-induced aggregation and 
enhanced transfection efﬁ  ciency compared to DNA/polyca-
tion complexes without modiﬁ  cation. But in above inves-
tigations the amount of carboxylic acid and ligand in the 
line of PEG derivative was discrete, so didn’t determine 
the amount of these molecules in PEG derivative. Finsinger 
and colleagues (2000) linked peptide with negative charge 
such as INF7 or YE5C to glutamic acid on PEG-glutamice 
acid copolymer, then modiﬁ  ed it on the surface of DNA 
complexes formed with PEI, PLL, or liposome, which 
obtained 2–20-folds higher efﬁ  ciency than control. How-
ever there is a lot of interferon-7 (INF7) or YE5C in each 
PEG-glutamic acid copolymer in this approach. Although 
these peptide made PEG to closely adsorb on the surface 
of complex, these discrete peptide in each PEG-glutamic 
acid copolymer maybe cause some complexes to aggregate 
to large complexes even precipitation.
In our study, we showed a nonviral gene delivery system 
composed of PLL-, DNA-, and PLG-conjugated PEG or 
EGF. Here we used PLG as a bridge between DNA/PLL 
complex and PEG or EGF. There is one PEG or EGF con-
jugated to each PLG through sole end amino group of PLG. 
The advantage of this system is that each complex with 
various amounts of PEG and/or EGF can be produced eas-
ily without making a new synthesis, and PEG or EGF can 
maximally stand at the surface of complexes. Then we can 
adjust the amount of PEG or EGF in this system as long as 
controlling the amount of PLG. So we were able to conve-
niently investigate the relation between the amounts of PEG 
and/or EGF in complexes and physicochemical property or 
cell transfection efﬁ  ciency of complexes.
Materials and methods
PLL (MW = 28, 500) was purchased from Sigma Chemical 
(St Louis, MO, USA) and used without further puriﬁ  cation. 
Recombinant human EGF (rhEGF) was purchased from 
Shanghai Bioengineering center (Shanghai, China). PLG 
(20 glutamic acid, purity: 95%) was synthesized by 
Shanghai Sangon Biological Engineering Technology 
and Service Co., Ltd (Shanghai, China). Succinimidyl 
4-[N-maleimidomethyl] cyclohexane-1-carboxylate 
(SMCC), N-succinimidyl 3-[2-pyridyldithio]-propion-
amido (SPDP) and slide-A-lyzer dialysis unit (3500, 10000 
MWCO) were purchased from Pierce Biotechnology. Inc. 
(Rockford, IL, USA). sc-mPEG (MW = 5000, 10000, 
20000, D = 1.12, sc cont: 90%) were synthesized by 
Xinfeng Biotechnology Co., Ltd (Shanghai, China). Fused-
silica capillary (75 µm ID) was purchased from Yongnian 
Optical Fiber Factory (Hebei, China). All other reagents 
were of analytical grade.
Cell culture
Human hepatoma cell line SMMC-7721 (a gift from Shanghai 
Cancer Institute, Shanghai Jiaotong University, China) was 
cultured in DMEM supplemented with 10% fetal bovine 
serum (FBS) at 37 °C in 5% CO2 atmosphere.
Synthesis of PEG-g-PLG copolymers
PEG-g-PLG was synthesized by coupling the amino group 
of PLG with various sc-mPEG as previously described (Guo 
et al 2004) with small modiﬁ  cation (Scheme 1). Brieﬂ  y, PLG 
and sc-mPEG (at molar ratio of 6:1) were dissolved in 0.05 M 
phosphate buffer (pH 7.4) and DMSO respectively. sc-mPEG 
was added to the PLG solution quickly and the solution was 
stirred under N2 atmosphere at room temperature for 8 hours, 
then dialyzed against ultra-pure water in dialysis unit (3500 
MWCO) twice for 3 h each.
Conjugation of PLG and EGF
Conjugation of PLG and EGF was referred to the method 
(Wagner et al 1990) with small modiﬁ  cation (Scheme 2). 
Brieﬂ  y, (1) 0.113 mg SPDP in DMSO was added to 1.5 mg 
EGF (the molar ratio of SPDP to EGF is 1.5:1) in phosphate 
buffers (pH 7.5) and quickly mixed. After reaction for 60 
min at room temperature, the product was dialyzed against 
deionic water twice for 3 hr each by using dialysis unit 
(3500 MWCO), and then lyophilized for next procedure. 
(2) Lyophilized EGF-SPDP was redissolved in acetate 
acid buffer (pH 4.5), in which 1.84 mg 1, 4-Dithiothreitol 
(DTT) (the molar ratio of DTT to SPDP is 17:1) was 
Scheme 1 The schematic picture of PLG grafted with PEG.International Journal of Nanomedicine 2008:3(2) 251
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added to activate the dithiol of SPDP on EGF-SPDP into 
sulphydryl group. After reaction for 30 min under N2 
at room temperature, the product was dialyzed against 
deionic water twice for 3 h each by using dialysis unit 
(3500 MWCO), and then lyophilized for next procedure. 
(3) 0.8 mg SMCC in DMSO was added to 6.3 mg PLG 
(the molar ratio of SMCC to PLG is 0.8:1) in phosphate 
buffer (pH 7.4) and quickly mixed. After reacting for 
60 min at room temperature, the product was ready for 
next procedure. (4) Lyophilized EGF-SPDP with sulphy-
dryl group was dissolved in phosphate buffer (pH 7.4) and 
then added into PLG-SMCC solution under stirring. The 
mixture was incubated for 20 h at 10 degree celsius. After 
reaction, the product was dialyzed against deionic water 
twice for 3 h each by using dialysis unit (3500 MWCO) 
and then lyophilized.
Preparation of coated capillary
The coated capillary in this study was prepared by our lab 
as previous described (Zhang et al 2004). Firstly capillary 
was washed by 0.1 M HCl, 0.1 M NaOH, and, water respec-
tively. Then the inside wall of capillary was silanylated by 
3-(trimethoxysilyl) propyl methacrylate. Finally the inside 
wall of capillary was coated by N, N-dimethylacrylamide. 
The coated capillary can be used after it has aged at room 
temperature overnight.
Characterization of PEG-g-PLG 
and EGF-g-PLG by capillary 
electrophoresis (CE)
A P/ACETM MDQ capillary electrophoresis system 
(Beckman, Fullerton, CA, USA) was equipped with the 
coated capillary (75 µm inner diameter). Samples were 
injected by pressure and the on column UV detection was 
set at 214 nm. The temperature of the capillary cartridge was 
maintained at 25 ± 0.1 °C.
Preparation of DNA/PLL/PLG 
conjugate complex
PLL solution with concentration of 1 mg/ml (the total charge 
ratio of amino group in PLL to phosphate in DNA and carbox-
ylic acid in PLG is 1:5, 1:3, 1:1, 3:1, or 5:1) was quickly mixed 
with 1 µg of pGL3 plasmid DNA with concentration of 1 mg/ml 
in HEPES buffer (pH 7.3, 10 mM) respectively and the mixture 
was incubated for 15 min at room temperature. Then PLG (or 
PEG-g-PLG, EGF-g-PLG) with concentration of 0.5 mg/ml 
(the charge ratio of phosphate in DNA to carboxylic acid in 
PLG is 1:5, 1:3, 1:1, 3:1, or 5:1) was incubated with DNA/PLL 
complex for 15 min at room temperature, respectively.
Size and zeta potential of DNA complex
The size and zeta potential of DNA and polymers complexes 
were measured by Photon Correlation Spectroscopy (PCS) 
Scheme 2 The schematic picture of PLG grafted with EGF.International Journal of Nanomedicine 2008:3(2) 252
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(Malvern Instruments Ltd. Worcestershire, UK) equipped 
with a He-Ne laser of 633 nm. DNA and polymers complexes 
with different composition was injected into detector and 
measured at 25 °C with the constant angle of 90°.
Nuclease resistance of DNA complexes
The ability of polymers to protect DNA from enzymatic 
degradation was evaluated by nuclease resistance assay as 
previous described (Lee et al 2001). Brieﬂ  y, 20 µl DNA 
complexes (1 µg DNA) were mixed with DNase I (1 unit/1 µg 
DNA) and the mixture was incubated for 20 min at 37 °C. 
Then the DNase I digestion was stopped by equal volume 
of stop solution (0.8 M NaCl, 50 mM EDTA) and 2 µl of 
10% SDS was added to the mixture to disassociate DNA 
from the complexes at 65 °C overnight. DNA was extracted 
from the mixture by the phenol/chloroform solution and 
precipitated in 75% ethanol, then applied to 0.8% agarose 
gel electrophoresis.
Cell transfection assay
In vitro transfection efﬁ  ciency of DNA complexes was tested 
in SMMC-7721 cells. Complexes containing 1 µg DNA were 
added into each well in the medium supplemented with or 
without 10% FBS. After incubating for 6 hr, medium with 
complexes was removed and substituted by 0.5 ml medium 
with 10% FBS. Cells were incubated for another 42 h. At the 
end of incubation, medium was removed and 200 µl of lysis 
buffer was added into each well to disassociate cells from 
plate. The lysed cells were collected and spun down. 50 µl 
of supernatant were mixed with 50 µl of luciferase reagent 
(Promega Corp, Wisconsin, USA), the luminescence value 
were detected by the TD-20/20 luminometer (Turnerbiosys-
tems Inc, California, USA).
Results and discussions
Characterization of PEG-g-PLG 
and EGF-g-PLG
When PLG was linked to PEG of various lengths, peak posi-
tion of PEG-g-PLG was obviously different when running in 
CE (Figure 1A). The longer the length of PEG, the shorter 
the peak time of PEG-g-PLG was. The peaks of PLG, EGF-
g-PLG and EGF were approximately appeared at 5th min, 
22nd min, and 29th min, respectively (Figure 1B).
Size and zeta potential of DNA complex
The size of complex gradually increased from about 58 nm, 
which was the size of DNA/PLL, when PEG-g-PLG was added 
at PLG to DNA charge ratio below 1 (Figure 2A). At the PLG 
to DNA charge ratio of 1, the largest size of complex contain-
ing PEG5000-g-PLG, PEG10000-g-PLG or PEG20000-g-PLG was 
about 78, 83, and 88 nm, respectively. Meanwhile the polydis-
persity index of these complexes, which was at the ranges of 
0.19 to 0.29, didn’t obviously change (Figure 2C). So it was 
believed that the addition of PEG-g-PLG to DNA/PLL didn’t 
lead to aggregate. In comparison, aggregation was observed 
by adding PLG alone in DNA/PLL complex (data not shown). 
The size of complex was correlated with the molecular weight 
of PEG-g-PLG, ie, the size of complex containing PEG20000-
g-PLG is larger than the size of complex containing PEG10000-
g-PLG, which is larger than the size of complex containing 
PEG5000-g-PLG (Figure 2B). At PLG to DNA ratio below 1, 
the size of complexes containing PEG20000-g-PLG, PEG10000-
g-PLG or PEG5000-g-PLG increased to 88 nm, 77 nm, and 71 
nm, respectively. At the same time the polydispersity index of 
complexes at about 0.22 didn’t obviously change (Figure 2D). 
It was believed that the addition of PEG-g-PLG did not lead to 
aggregation of complexes. When PLG to DNA charge ratio in 
complex was more than 1, further increase this ratio resulted 
in decrease of the complex size (Figure 2B). Meanwhile the 
polydispersity index of complexes gradually increased at PLG 
to DNA charge ratio above 1 (Figure 2D). This might be due 
to the binding of some PEG-g-PLG and excessive free PLL 
leading to formed smaller complex, so that the average size 
of complexes decreased and the polydispersity index of com-
plexes increased at PLG to DNA charge ratio above 1.
The δ-potential of complex containing PLG gradually 
decreased with increasing the amount of PLG in complex until 
PLG to DNA charge ratio of 2, at which ratio the δ-potential 
was about -30 mV (Figure 3A). It was believed that PLG was 
bind to DNA/PLL complex. This result was in agreement 
with the previous observations by Trubetskoy and colleagues 
(1999) and Finsinger and colleagues (2000), in which poly-
electrolytes with negative charge could be attached to the 
surface of condensed DNA particles and obviously decreased 
the zeta-potential of complexes. Trubetskoy and colleagues 
(1999) have observed that at the charge stoichiometry of 
DNA/PLL/SPLL close to 1:1:1 negative charge SPLL can 
form tertiary complexes with binary DNA/PLL complexes and 
make the complexes negative. Meanwhile adding PEG-g-PLG 
into DNA/PLL complex resulted in successfully shielding 
the δ-potential of complex at the PLG to DNA ratio above 
1 (Figure 3A). If adding excessive PLL into the complex, ie, 
the total positive charge to negative charge ratio is more than 
1, it was shown that the δ-potential of complex containing 
PEG20000-g-PLG or PEG10000-g-PLG obviously was lower International Journal of Nanomedicine 2008:3(2) 253
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than that containing PEG5000-g-PLG. Below this ratio, the 
δ-potential of complex formed with different molecule weight 
of PEG-g-PLG didn’t differ from each other (Figure 3B).
Nuclease resistance of DNA complexes
One concern of this system was that polyanion may dissoci-
ate DNA complexes by competing with DNA for binding 
to the polycation (Trubetskoy et al 1999). Another concern 
was whether PLG or PEG-g-PLG could substitute DNA 
from complexes or not. It has been shown that DNA could 
be released from the complexes by adding certain amount 
of polyanion to the complexes (Katayose and Kataoka 1998; 
Koyama et al 2002). Here it was shown that complexes 
containing PEG20000-g-PLG or PEG10000-g-PLG had stronger 
protection ability, in which DNA was not or a little digested 
by DNase I, than complexes containing PEG5000-g-PLG at 
positive to negative charge ratio of 1 (Figure 4). This was 
probably due to the formation of PEG palisade surrounding 
the ion-complex core of DNA and PLL segment of the block 
copolymer (Katayose and Kataoka 1998).
Cell transfection assay
At total positive to negative charge ratio below 1, the 
transfection efﬁ  ciency of complex was similar to control 
Figure 1 (A) The electropherogram of PLG (a), PEG5000-g-PLG (b), PEG10000-g-PLG (c), PEG20000-g-PLG (d). Running conditions: UV detection (the wavelength of 214 nm); coated 
capillary with a effective length of 50 cm, 75 µm I.D; phosphated buffer of 30 mM, pH 8.5; injected at 0.5psi for 5 sec; separated at −10 kv. (B) The electropherogram of PLG 
(a), EGF-g-PLG (b), EGF (c). Running conditions: UV detection (the wavelength of 214 nm); coated capillary with a effective length of 50 cm, 75 µm I.D; phosphated buffer of 
40 mM, pH 8.0; injected at 0.5psi for 5 sec; separated at −10 kv.
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Figure 2 The size (A) and polydispersity index (C) of DNA/PLL complexes formed with increasing the amount of PEG5000-g-PLG (), PEG10000-g-PLG () and PEG20000-g-PLG 
(S) at N/P ratio of 2 res pectively. The size (B) and polydispersity index (D) of DNA/PLL complexes formed with PEG5000-g-PLG (), PEG10000-g-PLG () and PEG20000-g-PLG 
(S) at total positive to negative charge ratio of 1 respectively.
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(Figure 5A), because when the charge amount of PLL was 
fewer than that of DNA, PEG20000-g-PLG and EGF hardly 
attached to the surface of complexes with negative charge. 
Meanwhile at total positive to negative charge ratio of 1, 
the complex showed the maximum transfection efﬁ  ciency 
which was about 10 times that of control. In comparison, 
at total positive to negative charge ratio of 3 and 5, the 
transfection efﬁ  ciency gradually decreased. This was due 
to that when the charge amount of PLL was more than that 
of DNA, PEG20000-g-PLG and EGF-g-PLG could adsorb 
to both DNA/PLL complexes and excess PLL. This is the 
similar to the transfection results with different charge ratio 
Figure 4 The effect of different molecular PEG-g-PLG on the resistance of complex 
to the digestion of DNase I at N/P ratio of 2 and the PLG to DNA charge ratio of 1. 
1. marker, 2. DNA, 3. PEG5000-g-PLG, 4. PEG10000-g-PLG and 5. PEG20000-g-PLG.
of DNA to PLG at total positive to negative charge ratio of 1 
(Figure 6B). Surplus PLL could competitively bind with 
PEG20000-g-PLG and EGF-g-PLG, because PLG was added 
into DNA/PLL complexes after DNA and PLL was mixed 
to form complexes, although the charge amount of PLL was 
equal to that of DNA and PLG.
The transfection efﬁ  ciency of complexes containing 
PEG5000-g-PLG was lower than complexes containing 
other length of PEG-g-PLG at the presence or absence of 
serum (Figure 5B), in which the transfection efﬁ  ciency of 
complexes containing PEG10000-g-PLG or PEG20000-g-PLG 
was about 20 to 25 times higher than control, probably 
because enzyme in cell could digest DNA without or with 
little protection. This was consistent with the result obtained 
from the assay of DNase I digestion in which complexes 
containing PEG5000-g-PLG have the worst resistance to 
DNase I among these complexes (Figure 4). Only EGF 
on the surface of complexes could obviously increase the 
transfection efﬁ  ciency of complexes which was higher than 
both PEG20000-g-PLG and EGF-g-PLG added into complexes 
in the medium without serum (Figure 6A). This was probably 
because the binding of EGF with EGFR on cell was inﬂ  u-
enced by the steric effect of PEG20000-g-PLG. But at medium 
with serum PEG20000-g-PLG could protect complexes from 
attacking of protein in serum, so the transfection efﬁ  ciency 
of complexes containing PEG20000-g-PLG and EGF-g-PLG 
was higher than complexes only containing EGF-g-PLG at 
this condition.
Conclusions
In summary, we presented a novel modiﬁ  cation method 
for gene delivery system in which PLG was used as 
surface modification loading backbone, to which PEG 
or EGF was linked, to form complexes with PLL and 
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DNA. This system possessed an appreciable advantage of 
modulating the amount of PEG and/or targeting peptide on 
the surface of complexes without the need to synthesize a 
new copolymer containing PEG and/or targeting peptide for 
each formulation. By using this method, it should be possible 
to determine the correlation between biological property or 
physicochemical property of complexes and the amount of 
PEG and/or targeting peptide in complexes and determine 
the best complex with optimal transfection efficiency. 
Although this system provided certain enhancement in cell 
transfection efﬁ  ciency, some modiﬁ  cation on this system 
should be taken. For example excessive PLL in DNA/PLL 
complexes had better be removed to decrease the effect of 
excessive PLL on the adsorption of PLG conjugates to the 
surface of DNA/PLL complexes.
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